• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $ASBP

    Aspire Biopharma Holdings Inc.

    Subscribe to $ASBP
    $ASBP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    IPO Year: 2022

    Exchange: NASDAQ

    Recent Analyst Ratings for Aspire Biopharma Holdings Inc.

    DatePrice TargetRatingAnalyst
    See more ratings

    Aspire Biopharma Holdings Inc. SEC Filings

    View All

    Aspire Biopharma Holdings Inc. filed SEC Form 8-K: Other Events

    8-K - Aspire Biopharma Holdings, Inc. (0001847345) (Filer)

    7/20/26 5:20:17 PM ET
    $ASBP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Aspire Biopharma Holdings Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - Aspire Biopharma Holdings, Inc. (0001847345) (Filer)

    6/22/26 4:35:33 PM ET
    $ASBP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Aspire Biopharma Holdings Inc. filed SEC Form 8-K: Other Events

    8-K - Aspire Biopharma Holdings, Inc. (0001847345) (Filer)

    6/12/26 5:15:29 PM ET
    $ASBP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Aspire Biopharma Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Aspire Biopharma Holdings, Inc. (0001847345) (Filer)

    6/12/26 10:26:16 AM ET
    $ASBP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 10-Q filed by Aspire Biopharma Holdings Inc.

    10-Q - Aspire Biopharma Holdings, Inc. (0001847345) (Filer)

    5/15/26 4:16:32 PM ET
    $ASBP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SCHEDULE 13G filed by Aspire Biopharma Holdings Inc.

    SCHEDULE 13G - Aspire Biopharma Holdings, Inc. (0001847345) (Subject)

    5/15/26 6:44:20 AM ET
    $ASBP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Aspire Biopharma Holdings Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

    8-K - Aspire Biopharma Holdings, Inc. (0001847345) (Filer)

    5/14/26 4:05:32 PM ET
    $ASBP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by Aspire Biopharma Holdings Inc.

    SCHEDULE 13G/A - Aspire Biopharma Holdings, Inc. (0001847345) (Subject)

    5/13/26 1:00:34 PM ET
    $ASBP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form DEFR14A filed by Aspire Biopharma Holdings Inc.

    DEFR14A - Aspire Biopharma Holdings, Inc. (0001847345) (Filer)

    5/12/26 4:35:19 PM ET
    $ASBP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form DEF 14A filed by Aspire Biopharma Holdings Inc.

    DEF 14A - Aspire Biopharma Holdings, Inc. (0001847345) (Filer)

    5/11/26 8:34:41 AM ET
    $ASBP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Aspire Biopharma Holdings Inc. Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: Director Fell Donald G. bought $7,800 worth of shares (20,000 units at $0.39) (SEC Form 4)

    4/A - Aspire Biopharma Holdings, Inc. (0001847345) (Issuer)

    6/10/25 5:25:23 PM ET
    $ASBP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Fell Donald G. increased direct ownership by 5% to 20,000 units (SEC Form 4)

    4 - Aspire Biopharma Holdings, Inc. (0001847345) (Issuer)

    6/6/25 5:00:59 PM ET
    $ASBP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Aspire Biopharma Holdings Inc. Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: Director Fell Donald G. bought $7,800 worth of shares (20,000 units at $0.39) (SEC Form 4)

    4/A - Aspire Biopharma Holdings, Inc. (0001847345) (Issuer)

    6/10/25 5:25:23 PM ET
    $ASBP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Fell Donald G. increased direct ownership by 5% to 20,000 units (SEC Form 4)

    4 - Aspire Biopharma Holdings, Inc. (0001847345) (Issuer)

    6/6/25 5:00:59 PM ET
    $ASBP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Aspire Biopharma Holdings Inc. Press Releases

    Fastest customizable press release news feed in the world

    View All

    Life Sciences Virtual Investor Forum Presentations Now Available for On-Demand Viewing

    NEW YORK, June 26, 2026 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the presentations from the June 24th & 25th Life Sciences Virtual Investor Forum are now available for on-demand viewing. REGISTER AND VIEW PRESENTATIONS HERE Select companies are accepting 1x1 management meeting requests through June 19th. Please Schedule 1x1 Meetings here. The presentations will be available 24/7 for 90 days. Investors, advisors, and analysts may download investor materials from the company’s resource section. Presenting Companies CompanyTicker(s)MetaVia Inc.(NASDAQ:MTVA)Nasus Pharma Ltd.(NYSE:NSRX)CytoSorbents Corporation(NASD

    6/26/26 8:35:00 AM ET
    $MTVA
    $NSRX
    $CTSO
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Medical/Dental Instruments
    Industrial Specialties

    Life Sciences Virtual Investor Forum Agenda Announced for June 24th & 25th

    NEW YORK, June 23, 2026 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the agenda for the Life Sciences Virtual Investor Forum, taking place June 24th & 25th, 2026. Individual investors, institutional investors, advisors, and analysts are invited to attend. REGISTER HERE Investors are encouraged to pre-register and run the online system check to expedite participation and receive event updates. Participation is free, and attendees may watch live company presentations and schedule one-on-one meetings with management teams. Schedule 1x1 meetings here. "This week's Life Sciences Virtual Investor Forum brings

    6/23/26 8:35:00 AM ET
    $MTVA
    $NSRX
    $CTSO
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Medical/Dental Instruments
    Industrial Specialties

    Aspire Biopharma to Present at the Life Sciences Investor Forum on June 25th

    ESTERO, Fla., June 17, 2026 (GLOBE NEWSWIRE) -- Aspire Biopharma Holdings, Inc.'s (NASDAQ:ASBP) ("Aspire" or the "Company"), today announced that it will present live at the Life Sciences Investor Forum hosted by VirtualInvestorConferences.com on June 25th, 2026. DATE: June 25th   TIME: 2:00 pm ET REGISTER HERE Available for 1x1 meetings: June 24-25. Schedule 1x1 Meetings here. The event will be conducted as a live, interactive online forum, offering investors and industry professionals within the life sciences community the opportunity to submit questions to management in real time. A replay of the webcast will be available following the conclusion of the conference. It is recommend

    6/17/26 10:57:42 AM ET
    $ASBP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Presenting on Emerging Growth Conference 81 Day 2 on April 17; Register to live stream

    MIAMI, April 16, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 80th Emerging Growth Conference on April 16 & 17, 2025. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Register for the Conference here. Submit Questions for any of the presenting companies to: Questions@EmergingGrowth.com For updates, follow us on Twitter Day 1 - TodayApril 16, 2025 9:00Virtual Lobby opens.Register for the Conference. If you already registered, go back to t

    4/16/25 7:00:00 AM ET
    $ASBP
    $BENF
    $BNZI
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Finance: Consumer Services
    Finance

    Presenting on Emerging Growth Conference 81 Day 1 on April 16; Register to live stream

    MIAMI, April 15, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 81th Emerging Growth Conference on April 16 & 17, 2025. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Register for the Conference here. Submit Questions for any of the presenting companies to: Questions@EmergingGrowth.com For updates, follow us on Twitter Day 1April 16, 2025 9:00Virtual Lobby opens.Register for the Conference. If you already register

    4/15/25 7:00:00 AM ET
    $ASBP
    $BENF
    $BNZI
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Finance: Consumer Services
    Finance